LNDC SCHEDULE 13G/A: SEC filing

Greenhaven Road Investment Management, L.P. and affiliated entities

Filed with the SEC on · accession 0000919574-26-008139

LNDC filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Greenhaven Road Investment Management, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,868,881 shares, or 7.6%, of Lifecore Biomedical, Inc. common stock as of September 30, 2026.

Summary of the filing

Greenhaven Road Investment Management, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,868,881 shares, or 7.6%, of Lifecore Biomedical, Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares beneficially owned by Greenhaven Road Investment Management, L.P., MVM Funds, LLC, and Scott Miller$2.9M
Shares beneficially owned by Greenhaven Road Capital Fund 1, L.P.$1.5M
Shares beneficially owned by Greenhaven Road Capital Fund 2, L.P.$1.4M
Reporting person / beneficial ownerGreenhaven Road Investment Management, L.P.
General partner of greenhaven road investment management, l.p.; reporting personMVM Funds, LLC
Reporting person / beneficial owner of 1,518,411 shares (4.0%)Greenhaven Road Capital Fund 1, L.P.
Reporting person / beneficial owner of 1,350,470 shares (3.6%)Greenhaven Road Capital Fund 2, L.P.
IssuerLifecore Biomedical, Inc.
Manager, mvm funds, llc (general partner of greenhaven road investment management, l.p.)Scott Miller

✦ Ask GOAX AI about this filing — what it means for LNDC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LNDC?

Click here

Frequently asked questions

What did LNDC file with the SEC on Nov 16, 2026?

LNDC filed a SCHEDULE 13G/A (SEC filing). Greenhaven Road Investment Management, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,868,881 shares, or 7.6%, of Lifecore Biomedical, Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other LNDC SEC filings

Get alerts when LNDC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days